These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 36030782)
21. [Quadruple regimens using domestically manufactured drugs in gastritis and duodenal ulcer patients for Helicobacter pylori eradication: a perspective, multicenter, randomized controlled trial]. Gao W; Hu F; Cheng H; Wang H; Yang Y; Liang H; Zhang S; Meng F; Cui M; Wei H; Sheng J; An HJ; Jiang B; Chen Y; Li Y; Zuo X; Gong J; Zhao P; Dong L; Wang B; Jiang K; Zhang G; Li J; Zhao Y; Gao H; Yang L Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(4):260-4. PubMed ID: 26879784 [TBL] [Abstract][Full Text] [Related]
22. NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management. Chan FK Drug Saf; 2005; 28(4):287-300. PubMed ID: 15783239 [TBL] [Abstract][Full Text] [Related]
24. Evaluation and management of patients with recurrent peptic ulcer disease after acid-reducing operations: a systematic review. Turnage RH; Sarosi G; Cryer B; Spechler S; Peterson W; Feldman M J Gastrointest Surg; 2003; 7(5):606-26. PubMed ID: 12850673 [TBL] [Abstract][Full Text] [Related]
25. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis. Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329 [TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers. Arkkila PE; Seppälä K; Kosunen TU; Sipponen P; Mäkinen J; Rautelin H; Färkkilä M Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):93-101. PubMed ID: 15647648 [TBL] [Abstract][Full Text] [Related]
28. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors]. Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498 [TBL] [Abstract][Full Text] [Related]
29. High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study. Poonyam P; Chotivitayatarakorn P; Vilaichone RK Asian Pac J Cancer Prev; 2019 Sep; 20(9):2859-2864. PubMed ID: 31554388 [TBL] [Abstract][Full Text] [Related]
30. [Peptic ulcer and Helicobacter pyrlori. Results and consequences of its eradication]. Ballesteros-Amozurrutia MA Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):41-9. PubMed ID: 11464621 [TBL] [Abstract][Full Text] [Related]
31. Is There Any Difference in the Eradication Rate of Helicobacter pylori Infection According to the Endoscopic Stage of Peptic Ulcer Disease? Seo SI; Kim SJ; Kim HS; Shin WG; Kim KH; Jang MK; Lee JH; Kim HY Helicobacter; 2015 Dec; 20(6):424-30. PubMed ID: 25752487 [TBL] [Abstract][Full Text] [Related]
32. Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users. Papatheodoridis GV; Archimandritis AJ World J Gastroenterol; 2005 Jul; 11(25):3811-6. PubMed ID: 15991274 [TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori infection and the use of NSAIDs. Bazzoli F; De Luca L; Graham DY Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040 [TBL] [Abstract][Full Text] [Related]
35. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease. Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092 [TBL] [Abstract][Full Text] [Related]
36. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases. Ji KY; Hu FL World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960 [TBL] [Abstract][Full Text] [Related]
37. Patients with endoscopic gastritis and/or duodenitis improve markedly following eradication of Helicobacter pylori, although less so than patients with ulcers. Olafsson S; Hatlebakk JG; Berstad A Scand J Gastroenterol; 2002 Dec; 37(12):1386-94. PubMed ID: 12523587 [TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy. Cherian PT; Cherian S; Singh P Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640 [TBL] [Abstract][Full Text] [Related]
39. Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study. Yilmaz S; Bayan K; Dursun M; Canoruç F; Kilinç N; Tüzün Y; Daniş R; Ertem M Dig Dis Sci; 2007 Jan; 52(1):110-8. PubMed ID: 17151802 [TBL] [Abstract][Full Text] [Related]
40. Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer. Jainan W; Vilaichone RK Asian Pac J Cancer Prev; 2014; 15(24):10957-60. PubMed ID: 25605208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]